Tiber Creek Group
Tiber Creek Group filed a Q4 report for Pharmaceutical Industry Labor Management Association on January 17, 2026, reporting $50,000 in lobbying income.
Lobbying for Pharmaceutical Industry Labor Management Association · Biopharmaceutical coalition supporting job creation and medical innovation.
Issues related to IP protection under Bayh Dole; Issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing.
Issues related to IP protection under Bayh Dole; Issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing.